Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Hydromorphone for Cesarean Section
NCT02067520Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydromorphone in postoperative pain, sponsored by Thomas Jefferson University. Primary endpoints: Optimal dose of IT hydromorphone at 24 hours, Morphine usage at 24 hours and 1 more. Started Jan 2014; status: completed.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02067520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067520.